IGC Pharma (IGC) Retained Earnings (2016 - 2025)
Historic Retained Earnings for Pharma (IGC) over the last 17 years, with Q3 2025 value amounting to -$122.8 million.
- Pharma's Retained Earnings fell 430.37% to -$122.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$122.8 million, marking a year-over-year decrease of 430.37%. This contributed to the annual value of -$120.7 million for FY2025, which is 622.8% down from last year.
- As of Q3 2025, Pharma's Retained Earnings stood at -$122.8 million, which was down 430.37% from -$122.3 million recorded in Q2 2025.
- Pharma's Retained Earnings' 5-year high stood at -$74.1 million during Q1 2021, with a 5-year trough of -$122.8 million in Q3 2025.
- Over the past 5 years, Pharma's median Retained Earnings value was -$102.7 million (recorded in 2023), while the average stood at -$102.0 million.
- Its Retained Earnings has fluctuated over the past 5 years, first tumbled by 2108.89% in 2022, then crashed by 430.37% in 2025.
- Over the past 5 years, Pharma's Retained Earnings (Quarter) stood at -$82.7 million in 2021, then fell by 16.91% to -$96.6 million in 2022, then fell by 14.64% to -$110.8 million in 2023, then fell by 7.95% to -$119.6 million in 2024, then fell by 2.71% to -$122.8 million in 2025.
- Its last three reported values are -$122.8 million in Q3 2025, -$122.3 million for Q2 2025, and -$120.7 million during Q1 2025.